tiprankstipranks
Trending News
More News >
Appili Therapeutics Inc Class A (TSE:APLI)
:APLI
Advertisement

Appili Therapeutics Inc Class A (APLI) Price & Analysis

Compare
26 Followers

APLI Stock Chart & Stats

C$0.03
>-C$0.01(-14.29%)
At close: 4:00 PM EST
C$0.03
>-C$0.01(-14.29%)

Appili Therapeutics Inc Class A News

APLI FAQ

What was Appili Therapeutics Inc Class A’s price range in the past 12 months?
Appili Therapeutics Inc Class A lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
    What is Appili Therapeutics Inc Class A’s market cap?
    Appili Therapeutics Inc Class A’s market cap is C$3.64M.
      When is Appili Therapeutics Inc Class A’s upcoming earnings report date?
      Appili Therapeutics Inc Class A’s upcoming earnings report date is Nov 13, 2025 which is in 21 days.
        How were Appili Therapeutics Inc Class A’s earnings last quarter?
        Appili Therapeutics Inc Class A released its earnings results on Aug 14, 2025. The company reported -C$0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.01.
          Is Appili Therapeutics Inc Class A overvalued?
          According to Wall Street analysts Appili Therapeutics Inc Class A’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Appili Therapeutics Inc Class A pay dividends?
            Appili Therapeutics Inc Class A does not currently pay dividends.
            What is Appili Therapeutics Inc Class A’s EPS estimate?
            Appili Therapeutics Inc Class A’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Appili Therapeutics Inc Class A have?
            Appili Therapeutics Inc Class A has 121,266,120 shares outstanding.
              What happened to Appili Therapeutics Inc Class A’s price movement after its last earnings report?
              Appili Therapeutics Inc Class A reported an EPS of -C$0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Appili Therapeutics Inc Class A?
                Currently, no hedge funds are holding shares in TSE:APLI

                Company Description

                Appili Therapeutics Inc Class A

                Appili Therapeutics Inc. is a biotechnology company focused on developing novel antimicrobial and antiviral therapies. The company operates primarily in the pharmaceutical sector, concentrating on addressing unmet medical needs related to infectious diseases. Appili's core products include its leading candidate, ATI-1501, which is an oral formulation of the antibiotic metronidazole, aimed at treating infections caused by Clostridium difficile. The company is also engaged in other projects focusing on the development of therapies for resistant bacterial infections and viral diseases.

                Appili Therapeutics Inc Class A (APLI) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Restart Life Sciences
                Rakovina Therapeutics Inc
                MYND Life Sciences
                Marvel Biosciences Corp
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis